Abstract

The proposed administrative supplement to the CTSA award at the Clinical and Translational Science Institute (CTSI) of Southeastern Wisconsin is a randomized blinded placebo-controlled trial to evaluate the efficacy of treatment with convalescent plasma (CP) in hospitalized patients with COVID-19. Studies have shown that CP is safe for transfusion in COVID-19 patients. However, this trial was developed to obtain scientific evidence to support or reject the hypothesis that CP may be a therapeutic option for COVID-19. The hypothesis underpinning this trial is that compared to placebo, administration of CP will avert respiratory deterioration, the main cause of death, and improve clinical status in patients hospitalized with COVID-19. This trial is being conducted across several sites that have experienced rapidly rising numbers of COVID-19 cases, including Miami, Florida, New York City, New York, and Houston Texas. Wisconsin is the new epicenter of the COVID-19 pandemic in the United States, and one of the global hot spots. This study is within the scope of the existing CTSA award, with its focus on network trials and rapid site initiation and team science, and leverages the CTSI's focus on mobilizing resources in response to rapidly emerging infectious diseases. Wisconsin will serve as a new site in this quickly designed and launched trial, building upon the work already done in NYC to develop a multicenter, well-powered trial via regional collaborations and CTSA consortium partnerships.

Public Health Relevance

The proposed project is a randomized blinded placebo-controlled trial to evaluate the efficacy of treatment with convalescent plasma (CP) in hospitalized patients with COVID-19. The hypothesis underpinning this trial is that compared to placebo, administration of CP will avert respiratory deterioration, the main cause of death, and improve clinical status in patients hospitalized with COVID-19. The study has the potential to greatly impact the manner in which COVID-19 is treated in hospitalized patients, as well as impact the course of vaccine development, and could save lives around the world.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001436-06S2
Application #
10300655
Study Section
Program Officer
Rosemond, Erica K
Project Start
2020-12-28
Project End
2025-05-31
Budget Start
2020-12-28
Budget End
2021-05-31
Support Year
6
Fiscal Year
2021
Total Cost
Indirect Cost

  Institution

Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226

  Publications

Hyngstrom, Allison S; Murphy, Spencer A; Nguyen, Jennifer et al. (2018) Ischemic conditioning increases strength and volitional activation of paretic muscle in chronic stroke: a pilot study. J Appl Physiol (1985) 124:1140-1147
Lerma, Nicholas L; Cho, Chi C; Swartz, Ann M et al. (2018) Isotemporal Substitution of Sedentary Behavior and Physical Activity on Function. Med Sci Sports Exerc 50:792-800
Knight, Jennifer M; Kerswill, Stephanie A; Hari, Parameswaran et al. (2018) Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation. BMC Cancer 18:593
Jim, Heather S L; Sutton, Steven; Majhail, Navneet S et al. (2018) Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial. Bone Marrow Transplant 53:1038-1043
Turcotte, Lucie M; Wang, Tao; Hemmer, Michael T et al. (2018) Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone Marrow Transplant 53:932-937
Lee, Daniel J; Woertz, Erica N; Visotcky, Alexis et al. (2018) The Henle Fiber Layer in Albinism: Comparison to Normal and Relationship to Outer Nuclear Layer Thickness and Foveal Cone Density. Invest Ophthalmol Vis Sci 59:5336-5348
Spellecy, Ryan; Eve, Ann Marie; Connors, Emily R et al. (2018) The Real-Time IRB: A Collaborative Innovation to Decrease IRB Review Time. J Empir Res Hum Res Ethics 13:432-437
Strampe, Margaret R; Huckenpahler, Alison L; Higgins, Brian P et al. (2018) Intraobserver Repeatability and Interobserver Reproducibility of Ellipsoid Zone Measurements in Retinitis Pigmentosa. Transl Vis Sci Technol 7:13
Skinner, Nathan P; Lee, Seung-Yi; Kurpad, Shekar N et al. (2018) Filter-probe diffusion imaging improves spinal cord injury outcome prediction. Ann Neurol 84:37-50
Morrison, Andrea K; Myrvik, Matthew P; Brousseau, David C et al. (2018) Parents' pain medication underdosing is associated with more emergency department visits in sickle cell disease. Pediatr Blood Cancer 65:

Showing the most recent 10 out of 90 publications